Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Casopis Lekaru Ceskych
|
September 13, 2022
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience
Barbora Pipek, Hana Valentová, Petr Fojtík, et al.
Vnitrni Lekarstvi
|
June 2, 2021
Extraintestinal complications of inflammatory bowel diseases
Vít Navrátil, Silvia Cveková, Peter Slodička, et al.
Vnitrni Lekarstvi
|
June 21, 2016
The efficacy of treatment of local residual neoplasia under standardized conditions
Ondřej Urban, Barbora Pipek, Ivana Mikoviny Kajzrlíková, et al.
Crohn'S & Colitis 360
|
May 25, 2026
Urinary biomarkers of urolithiasis risk in Crohn's disease: hyperoxaluria, hypocitraturia, and hypomagnesuria in patients with and without ileocolic resection
Vit Navratil, Barbora Pipek, Premysl Falt, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
|
June 23, 2021
Administration of mucolytic solution before upper endoscopy - double-blind, monocentric, randomized study
Michal Stepan, Premysl Falt, Barbora Pipek, et al.
European Journal of Pediatrics
|
July 18, 2024
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort
Katarina Mitrova, Karin Cerna, Kristyna Zdychyncova, et al.
Therapeutic Advances in Gastroenterology
|
April 2, 2026
Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry
Ondrej Hradsky, Dana Duricova, Milan Lukas, et al.
Therapeutic Advances in Gastroenterology
|
August 16, 2021
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
Katarina Mitrova, Barbora Pipek, Martin Bortlik, et al.
Journal of Crohn'S & Colitis
|
June 16, 2022
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
Katarina Mitrova, Barbora Pipek, Martin Bortlik, et al.
Journal of Crohn'S & Colitis
|
June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study
Uria Shani, Monica State, Radu Bogdan Mateescu, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Casopis Lekaru Ceskych
|
September 13, 2022
Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience
Barbora Pipek, Hana Valentová, Petr Fojtík, et al.
Vnitrni Lekarstvi
|
June 2, 2021
Extraintestinal complications of inflammatory bowel diseases
Vít Navrátil, Silvia Cveková, Peter Slodička, et al.
Vnitrni Lekarstvi
|
June 21, 2016
The efficacy of treatment of local residual neoplasia under standardized conditions
Ondřej Urban, Barbora Pipek, Ivana Mikoviny Kajzrlíková, et al.
Crohn'S & Colitis 360
|
May 25, 2026
Urinary biomarkers of urolithiasis risk in Crohn's disease: hyperoxaluria, hypocitraturia, and hypomagnesuria in patients with and without ileocolic resection
Vit Navratil, Barbora Pipek, Premysl Falt, et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
|
June 23, 2021
Administration of mucolytic solution before upper endoscopy - double-blind, monocentric, randomized study
Michal Stepan, Premysl Falt, Barbora Pipek, et al.
European Journal of Pediatrics
|
July 18, 2024
Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort
Katarina Mitrova, Karin Cerna, Kristyna Zdychyncova, et al.
Therapeutic Advances in Gastroenterology
|
April 2, 2026
Persistence of advanced therapies in patients with ulcerative colitis: real-world data from the nationwide CREdIT registry
Ondrej Hradsky, Dana Duricova, Milan Lukas, et al.
Therapeutic Advances in Gastroenterology
|
August 16, 2021
Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study
Katarina Mitrova, Barbora Pipek, Martin Bortlik, et al.
Journal of Crohn'S & Colitis
|
June 16, 2022
Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study
Katarina Mitrova, Barbora Pipek, Martin Bortlik, et al.
Journal of Crohn'S & Colitis
|
June 10, 2025
The effectiveness of second- and-third-line biologics in perianal Crohn's disease-a multicenter propensity score-matched study
Uria Shani, Monica State, Radu Bogdan Mateescu, et al.
Page
of 1